Literature DB >> 1976569

RNA pseudoknot domain of tobacco mosaic virus can functionally substitute for a poly(A) tail in plant and animal cells.

D R Gallie1, V Walbot.   

Abstract

The genomes of many RNA viruses terminate in a tertiary structure similar to the L-conformation of tRNAs and this structure is recognized by many tRNA-specific enzymes such as aminoacyl-tRNA synthetase. Virtually the entire 3'-untranslated region (UTR) of tobacco mosaic virus (TMV) RNA is involved in an extended tertiary structure containing, in addition to a tRNA-like structure, a pseudoknot domain that lies immediately upstream. Although the functions of these structures are not well understood, they are essential to the virus. We demonstrate that the addition of the 204-base TMV 3'-untranslated region to foreign mRNA constructs can increase gene expression up to 100-fold compared to nonadenylated mRNA. The 3'-UTR of TMV was equal to or greater than a polyadenylated tail in enhancing gene expression in electroporated dicot and monocot protoplasts. The TMV 3'-UTR is functionally similar to a polyadenylated tail in that it increases mRNA stability and translation and must be positioned at the 3' terminus to function efficiently. Similar effects on expression were observed in Chinese hamster ovary cells, demonstrating that the sequence functions in a wide range of eukaryotes. When the extended tertiary structure was dissected, the upstream pseudoknot domain was found to be largely responsible for increasing expression. The inclusion of the tRNA-like structure, however, was important for full regulation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1976569     DOI: 10.1101/gad.4.7.1149

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  55 in total

1.  A phylogenetically conserved hairpin-type 3' untranslated region pseudoknot functions in coronavirus RNA replication.

Authors:  G D Williams; R Y Chang; D A Brian
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  A four-nucleotide translation enhancer in the 3'-terminal consensus sequence of the nonpolyadenylated mRNAs of rotavirus.

Authors:  V Chizhikov; J T Patton
Journal:  RNA       Date:  2000-06       Impact factor: 4.942

3.  Structure and function of a cap-independent translation element that functions in either the 3' or the 5' untranslated region.

Authors:  L Guo; E Allen; W A Miller
Journal:  RNA       Date:  2000-12       Impact factor: 4.942

4.  A mutation in GRS1, a glycyl-tRNA synthetase, affects 3'-end formation in Saccharomyces cerevisiae.

Authors:  C Magrath; L E Hyman
Journal:  Genetics       Date:  1999-05       Impact factor: 4.562

5.  Identification of the motifs within the tobacco mosaic virus 5'-leader responsible for enhancing translation.

Authors:  D R Gallie; V Walbot
Journal:  Nucleic Acids Res       Date:  1992-09-11       Impact factor: 16.971

Review 6.  Translational control in positive strand RNA plant viruses.

Authors:  Theo W Dreher; W Allen Miller
Journal:  Virology       Date:  2006-01-05       Impact factor: 3.616

7.  Structures required for poly(A) tail-independent translation overlap with, but are distinct from, cap-independent translation and RNA replication signals at the 3' end of Tobacco necrosis virus RNA.

Authors:  Ruizhong Shen; W Allen Miller
Journal:  Virology       Date:  2006-10-04       Impact factor: 3.616

8.  Contributions of the brome mosaic virus RNA-3 3'-nontranslated region to replication and translation.

Authors:  F C Lahser; L E Marsh; T C Hall
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

9.  The 3' untranslated region of satellite tobacco necrosis virus RNA stimulates translation in vitro.

Authors:  X Danthinne; J Seurinck; F Meulewaeter; M Van Montagu; M Cornelissen
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

10.  Lipid-mediated delivery of RNA is more efficient than delivery of DNA in non-dividing cells.

Authors:  S Zou; K Scarfo; M H Nantz; J G Hecker
Journal:  Int J Pharm       Date:  2010-01-18       Impact factor: 5.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.